Copyright
©The Author(s) 2024.
World J Gastrointest Endosc. Mar 16, 2024; 16(3): 168-174
Published online Mar 16, 2024. doi: 10.4253/wjge.v16.i3.168
Published online Mar 16, 2024. doi: 10.4253/wjge.v16.i3.168
Table 1 Clinical characteristics of the patients, n (%)
| Group P | n = 101 | Group C | n = 297 | ||
| Age, median (range) | 75 | (48–93) | 75 | (40–90) | 0.8831 |
| Sex | |||||
| Male | 72 | (71.3) | 219 | (73.7) | 0.3676 |
| Female | 29 | (28.7) | 78 | (26.3) | |
| Diabetes mellitus | 17 | (16.8) | 41 | (13.8) | 0.7054 |
| Chronic kidney disease on dialysis | 3 | (3.0) | 4 | (1.4) | 0.9287 |
| Liver cirrhosis | 7 | (6.9) | 9 | (3.0) | 0.7777 |
| Anti-platelet agents | 14 | (13.9) | 65 | (21.9) | 0.1485 |
| Continuation | 3 | (3.0) | 18 | (6.1) | |
| Discontinuation | 11 | (10.9) | 47 | (15.8) | |
| Duration of re-starting, median (range) | |||||
| Anticoagulants | 10 | (9.9) | 28 | (9.5) | 0.9355 |
| Continuation | 3 | (3.0) | 6 | (2.0) | |
| Discontinuation | 7 | (6.9) | 22 | (7.5) | |
| Helicobacter pylori infection status | |||||
| Not infected | 2 | (2.0) | 15 | (5.1) | 0.1524 |
| Persistent infection | 27 | (26.7) | 92 | (31.0) | |
| After eradIcation | 72 | (71.3) | 189 | (63.6) | |
| Unknown | 0 | (0.0) | 1 | (0.3) |
- Citation: Gomi K, Yamamoto Y, Yoshida E, Tohata M, Nagahama M. Using a novel hemostatic peptide solution to prevent bleeding after endoscopic submucosal dissection of a gastric tumor. World J Gastrointest Endosc 2024; 16(3): 168-174
- URL: https://www.wjgnet.com/1948-5190/full/v16/i3/168.htm
- DOI: https://dx.doi.org/10.4253/wjge.v16.i3.168